US Patent Issued to TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH on Sept. 15 for "Polypeptide derivative having dual receptor agonistic action and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,467, issued on Sept. 15, was assigned to TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH Co. LTD. (Tianjin, China).

"Polypeptide derivative having dual receptor agonistic action and use thereof" was invented by Yingmei Han (Tianjin, China), Wei Liu (Tianjin, China), Bingni Liu (Tianjin, China), Weiling Kong (Tianjin, China), Naxia Zhao (Tianjin, China), Guangping Xia (Tianjin, China), Qian Shang (Tianjin, China), Jing Jin (Tianjin, China), Xiaohua Kong (Tianjin, China), Yuquan Li (Tianjin, China) and Songhui Wang (Tianjin, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a polypeptide derivative, or a modified deriva...